Clinical Trial Update: Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis [Phase 4]

View source ↗

Summary

This Phase 4 trial compared an oral prednisone taper to placebo for treating acute relapses in multiple sclerosis. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Claudio Gobbi | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED